https://scholars.lib.ntu.edu.tw/handle/123456789/594523| Title: | Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary? | Authors: | JIEN-JIUN CHEN LIAN-YU LIN Yang Y.-H. HWANG, JUEY-JEN PAU-CHUNG CHEN JIUNN-LEE LIN |
Issue Date: | 2015 | Publisher: | Elsevier Ireland Ltd | Journal Volume: | 196 | Start page/Pages: | 53 | Source: | International Journal of Cardiology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937440171&doi=10.1016%2fj.ijcard.2015.05.162&partnerID=40&md5=904f6322035aebb60d7c3adda3c3a88f https://scholars.lib.ntu.edu.tw/handle/123456789/594523 |
ISSN: | 0167-5273 | DOI: | 10.1016/j.ijcard.2015.05.162 | SDG/Keyword: | [SDGs]SDG3 acetylsalicylic acid; anticoagulant agent; antithrombocytic agent; clopidogrel; ticlopidine; warfarin; anticoagulant agent; antithrombocytic agent; anticoagulant therapy; atrial fibrillation; bleeding tendency; brain hemorrhage; brain ischemia; CHADS2 score; drug effect; end stage renal disease; high risk patient; human; Letter; long term care; neuroprotection; priority journal; propensity score; proportional hazards model; atrial fibrillation; brain ischemia; female; Kidney Failure, Chronic; male; Stroke; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Female; Humans; Kidney Failure, Chronic; Male; Platelet Aggregation Inhibitors; Stroke |
| Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.